As Lotus expands global access to medicines through a diversified portfolio, we grow responsibly by maximizing positive impact on people and communities while minimizing our environmental footprint.
Sustainability Overview
ESG Highlights 2024
Environmental
9
%
reduction in GHG emission intensity compared to the previous year in Taiwan and Korea
2
%
reduction in water intensity compared to the previous year in Taiwan and Korea plants
483
TCO2
Reduction by HVAC energy-saving
Social
87
SKUS
Launched in Asian and export markets
44.4
%
Female senior managers in Taiwan, Korea, Singapore, and India
>NT$26
MILLION
contributed to social engagement
Governance
0
Information security incidents
A
LEVEL
MSCI ESG rating
45
%
female board members
Aligning Strategy with Impact
Lotus integrates environmental, social and governance goals into our operations to drive responsible and sustainable growth. Our sustainability strategy is built on four pillars: minimizing environmental impact, expanding our product portfolio, fostering a culture of diversity, equity, and inclusion (DEI), and enhancing stakeholder engagement. These efforts collectively support Lotus’ long-term growth and reflect our commitment to addressing unmet medical needs.
Our Path to Sustainability
Environmental Sustainability
SUSTAINABILITY EXECUTION FOCUS
Lotus Awards
2021
2022
2023
2024
2025
Global Generics & Biosimilars Awards 2021
Finalist for Company of the Year, Asia-Pacific
Corporate Livewire
Taiwan Prestige for Pharmaceutical Company of the Year
Enterprise Asia
Corporate Excellence Award
BITSIGHT Cybersecurity Rating
Ranked 730 among 5,365 companies in the same industry globally
Taiwan Bio Industry Organization
Outstanding Company of the Year 2024
21st Century Foundation
Net Zero Industry Competitiveness Award (Excellence)
MSCI ESG Rating
Ranked at A level
HR Asia
Consecutively awarded as the Best Companies to Work for in Asia for 4 years, Diversity, Sustainable Workplace Award 2025, Tech Empowerment Award 2025
